astrazeneca glp 1 drug Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds AZ's GLP-1 Bydureon and SGLT2

There is no foolproof way to determine this

Klausen, M

If Zepbound causes significant changes in blood sugar levels, it might contribute to muscle spasms, including those involving the eyelids

When treatment is discontinued, weight regain and the deterioration of multiple cardiometabolic risk factors are common

Depending on the drug, Phase 3 can take one to four years

The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. GLP-1 receptor agonist drugs carry serious side effects ranging from nausea and vomiting to pancreatitis, acute kidney injury, bowel obstruction, and medullary thyroid cancer, the Ministry of Health and Family Welfare warned on 1 April, 2026